China's market will be largely driven by continued market reforms, prominence of policy-driven thematic opportunities, diversification benefits, and tailwinds from institutional participation. Alibaba Given COVID impact and the soft macro climate, China's e-commerce might remain weak. VAT impact in Europe, geopolitics, and FX fluctuations could pressure International Commerce. However, we expect the new businesses loss to improve via cost discipline and efficiency gain. We se
Most Notable: regeneron v mylan: regeneron does not seek injunctive relief but new patents filed moderna v alnylam: rejection of moderna's defense on no liability for monetary damages; patent owner needs to sue jnj v amgen: amgen producing biosimilar before patent expired
